Hannelouise Kissow

Hannelouise Kissow

Associate Professor

  1. 2019
  2. Published

    Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis

    Billeschou, A., Hunt, Jenna Elizabeth & Kissow, Hannelouise, 12 May 2019, In : Journal of visualized experiments : JoVE. 147, e59236.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Glucagon-like peptide-1 is a marker of systemic inflammation in patients treated with high-dose chemotherapy and autologous stem cell transplantation

    Ebbesen, M. S., Kissow, Hannelouise, Hartmann, Bolette, Grell, Kathrine, Gørløv, J. S., Kielsen, K., Holst, Jens Juul & Muller, Klaus, 2019, In : Biology of Blood and Marrow Transplantation. 25, 6, p. 1085-1091 7 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

    Naimi, R. M., Hvistendahl, M., Enevoldsen, L. H., Madsen, J. L., Fuglsang, S., Poulsen, Steen Seier, Kissow, Hannelouise, Pedersen, J., Nerup, N., Ambrus, R., Achiam, Michael Patrick, Svendsen, L. B., Holst, Jens Juul, Hartmann, Bolette, Hansen, S. H., Dragsted, Lars Ove, Steensberg, A., Mouritzen, U., Hansen, M. B. & Jeppesen, Palle Bekker, 2019, In : The Lancet Gastroenterology and Hepatology. 4, 5, p. 354-363 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Animal models of mucositis: critical tools for advancing pathobiological understanding and identifying therapeutic targets

    Wardill, H. R., Tissing, W. J. E., Kissow, Hannelouise & Stringer, A. M., 2019, In : Current Opinion in Supportive and Palliative Care. 13, 2, p. 119-133

    Research output: Contribution to journalReviewResearchpeer-review

ID: 925016